17 Feb Approval of the first direct-to-PCR COVID-19 test in the UK under CTDA legislation

Posted at 07:00h in Board, Novacyt Group, Products by

Paris, France and Camberley, UK – 17 February 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s PROmate® COVID-19 2G Real-Time PCR test has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (“CTDA”).

https://novacyt.com/wp-content/uploads/2022/02/Novacyt-CTDA-approval-of-PROmate-2G.pdf